Broad neutralizing antibody-based strategies to tackle influenza
Influenza viruses cause occasional pandemics and annual epidemics, thus persist as a threat to human society. The high variability of viral envelope proteins resulting from antigenic shift and antigenic drift allows influenza viruses to escape human herd immunity. During the past decade, along with...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Sun, Xiaoyu [verfasserIn] Ling, Zhiyang [verfasserIn] Yang, Zhuo [verfasserIn] Sun, Bing [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022 |
|---|
| Übergeordnetes Werk: |
Enthalten in: No title available - 53 |
|---|---|
| Übergeordnetes Werk: |
volume:53 |
| DOI / URN: |
10.1016/j.coviro.2022.101207 |
|---|
| Katalog-ID: |
ELV007849214 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV007849214 | ||
| 003 | DE-627 | ||
| 005 | 20230509145018.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230507s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.coviro.2022.101207 |2 doi | |
| 035 | |a (DE-627)ELV007849214 | ||
| 035 | |a (ELSEVIER)S1879-6257(22)00014-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sun, Xiaoyu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Broad neutralizing antibody-based strategies to tackle influenza |
| 264 | 1 | |c 2022 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Influenza viruses cause occasional pandemics and annual epidemics, thus persist as a threat to human society. The high variability of viral envelope proteins resulting from antigenic shift and antigenic drift allows influenza viruses to escape human herd immunity. During the past decade, along with the breakthroughs of human monoclonal antibody technologies, many broad reactive monoclonal antibodies (mAbs) that neutralize diverse influenza subtypes have been isolated and characterized. The achievements in this field have provided potential candidates of anti-influenza therapeutics and shed light on the design of universal influenza vaccines. Here, we review the broad neutralizing antibodies (bnAbs) targeting the virus surface proteins, summarize their epitopes, broad spectrum and immunological mechanisms of action and discuss the design of universal influenza vaccines inspired by bnAbs. | ||
| 700 | 1 | |a Ling, Zhiyang |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Zhuo |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Bing |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t No title available |g 53 |w (DE-627)ELV000891088 |x 1879-6257 |7 nnns |
| 773 | 1 | 8 | |g volume:53 |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 951 | |a AR | ||
| 952 | |d 53 | ||
| author_variant |
x s xs z l zl z y zy b s bs |
|---|---|
| matchkey_str |
article:18796257:2022----::ranurlznatbdbsdtaeiso |
| hierarchy_sort_str |
2022 |
| publishDate |
2022 |
| allfields |
10.1016/j.coviro.2022.101207 doi (DE-627)ELV007849214 (ELSEVIER)S1879-6257(22)00014-1 DE-627 ger DE-627 rda eng Sun, Xiaoyu verfasserin aut Broad neutralizing antibody-based strategies to tackle influenza 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Influenza viruses cause occasional pandemics and annual epidemics, thus persist as a threat to human society. The high variability of viral envelope proteins resulting from antigenic shift and antigenic drift allows influenza viruses to escape human herd immunity. During the past decade, along with the breakthroughs of human monoclonal antibody technologies, many broad reactive monoclonal antibodies (mAbs) that neutralize diverse influenza subtypes have been isolated and characterized. The achievements in this field have provided potential candidates of anti-influenza therapeutics and shed light on the design of universal influenza vaccines. Here, we review the broad neutralizing antibodies (bnAbs) targeting the virus surface proteins, summarize their epitopes, broad spectrum and immunological mechanisms of action and discuss the design of universal influenza vaccines inspired by bnAbs. Ling, Zhiyang verfasserin aut Yang, Zhuo verfasserin aut Sun, Bing verfasserin aut Enthalten in No title available 53 (DE-627)ELV000891088 1879-6257 nnns volume:53 GBV_USEFLAG_U SYSFLAG_U GBV_ELV AR 53 |
| spelling |
10.1016/j.coviro.2022.101207 doi (DE-627)ELV007849214 (ELSEVIER)S1879-6257(22)00014-1 DE-627 ger DE-627 rda eng Sun, Xiaoyu verfasserin aut Broad neutralizing antibody-based strategies to tackle influenza 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Influenza viruses cause occasional pandemics and annual epidemics, thus persist as a threat to human society. The high variability of viral envelope proteins resulting from antigenic shift and antigenic drift allows influenza viruses to escape human herd immunity. During the past decade, along with the breakthroughs of human monoclonal antibody technologies, many broad reactive monoclonal antibodies (mAbs) that neutralize diverse influenza subtypes have been isolated and characterized. The achievements in this field have provided potential candidates of anti-influenza therapeutics and shed light on the design of universal influenza vaccines. Here, we review the broad neutralizing antibodies (bnAbs) targeting the virus surface proteins, summarize their epitopes, broad spectrum and immunological mechanisms of action and discuss the design of universal influenza vaccines inspired by bnAbs. Ling, Zhiyang verfasserin aut Yang, Zhuo verfasserin aut Sun, Bing verfasserin aut Enthalten in No title available 53 (DE-627)ELV000891088 1879-6257 nnns volume:53 GBV_USEFLAG_U SYSFLAG_U GBV_ELV AR 53 |
| allfields_unstemmed |
10.1016/j.coviro.2022.101207 doi (DE-627)ELV007849214 (ELSEVIER)S1879-6257(22)00014-1 DE-627 ger DE-627 rda eng Sun, Xiaoyu verfasserin aut Broad neutralizing antibody-based strategies to tackle influenza 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Influenza viruses cause occasional pandemics and annual epidemics, thus persist as a threat to human society. The high variability of viral envelope proteins resulting from antigenic shift and antigenic drift allows influenza viruses to escape human herd immunity. During the past decade, along with the breakthroughs of human monoclonal antibody technologies, many broad reactive monoclonal antibodies (mAbs) that neutralize diverse influenza subtypes have been isolated and characterized. The achievements in this field have provided potential candidates of anti-influenza therapeutics and shed light on the design of universal influenza vaccines. Here, we review the broad neutralizing antibodies (bnAbs) targeting the virus surface proteins, summarize their epitopes, broad spectrum and immunological mechanisms of action and discuss the design of universal influenza vaccines inspired by bnAbs. Ling, Zhiyang verfasserin aut Yang, Zhuo verfasserin aut Sun, Bing verfasserin aut Enthalten in No title available 53 (DE-627)ELV000891088 1879-6257 nnns volume:53 GBV_USEFLAG_U SYSFLAG_U GBV_ELV AR 53 |
| allfieldsGer |
10.1016/j.coviro.2022.101207 doi (DE-627)ELV007849214 (ELSEVIER)S1879-6257(22)00014-1 DE-627 ger DE-627 rda eng Sun, Xiaoyu verfasserin aut Broad neutralizing antibody-based strategies to tackle influenza 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Influenza viruses cause occasional pandemics and annual epidemics, thus persist as a threat to human society. The high variability of viral envelope proteins resulting from antigenic shift and antigenic drift allows influenza viruses to escape human herd immunity. During the past decade, along with the breakthroughs of human monoclonal antibody technologies, many broad reactive monoclonal antibodies (mAbs) that neutralize diverse influenza subtypes have been isolated and characterized. The achievements in this field have provided potential candidates of anti-influenza therapeutics and shed light on the design of universal influenza vaccines. Here, we review the broad neutralizing antibodies (bnAbs) targeting the virus surface proteins, summarize their epitopes, broad spectrum and immunological mechanisms of action and discuss the design of universal influenza vaccines inspired by bnAbs. Ling, Zhiyang verfasserin aut Yang, Zhuo verfasserin aut Sun, Bing verfasserin aut Enthalten in No title available 53 (DE-627)ELV000891088 1879-6257 nnns volume:53 GBV_USEFLAG_U SYSFLAG_U GBV_ELV AR 53 |
| allfieldsSound |
10.1016/j.coviro.2022.101207 doi (DE-627)ELV007849214 (ELSEVIER)S1879-6257(22)00014-1 DE-627 ger DE-627 rda eng Sun, Xiaoyu verfasserin aut Broad neutralizing antibody-based strategies to tackle influenza 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Influenza viruses cause occasional pandemics and annual epidemics, thus persist as a threat to human society. The high variability of viral envelope proteins resulting from antigenic shift and antigenic drift allows influenza viruses to escape human herd immunity. During the past decade, along with the breakthroughs of human monoclonal antibody technologies, many broad reactive monoclonal antibodies (mAbs) that neutralize diverse influenza subtypes have been isolated and characterized. The achievements in this field have provided potential candidates of anti-influenza therapeutics and shed light on the design of universal influenza vaccines. Here, we review the broad neutralizing antibodies (bnAbs) targeting the virus surface proteins, summarize their epitopes, broad spectrum and immunological mechanisms of action and discuss the design of universal influenza vaccines inspired by bnAbs. Ling, Zhiyang verfasserin aut Yang, Zhuo verfasserin aut Sun, Bing verfasserin aut Enthalten in No title available 53 (DE-627)ELV000891088 1879-6257 nnns volume:53 GBV_USEFLAG_U SYSFLAG_U GBV_ELV AR 53 |
| language |
English |
| source |
Enthalten in No title available 53 volume:53 |
| sourceStr |
Enthalten in No title available 53 volume:53 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| isfreeaccess_bool |
false |
| container_title |
No title available |
| authorswithroles_txt_mv |
Sun, Xiaoyu @@aut@@ Ling, Zhiyang @@aut@@ Yang, Zhuo @@aut@@ Sun, Bing @@aut@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000891088 |
| id |
ELV007849214 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV007849214</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230509145018.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230507s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.coviro.2022.101207</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV007849214</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1879-6257(22)00014-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sun, Xiaoyu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Broad neutralizing antibody-based strategies to tackle influenza</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Influenza viruses cause occasional pandemics and annual epidemics, thus persist as a threat to human society. The high variability of viral envelope proteins resulting from antigenic shift and antigenic drift allows influenza viruses to escape human herd immunity. During the past decade, along with the breakthroughs of human monoclonal antibody technologies, many broad reactive monoclonal antibodies (mAbs) that neutralize diverse influenza subtypes have been isolated and characterized. The achievements in this field have provided potential candidates of anti-influenza therapeutics and shed light on the design of universal influenza vaccines. Here, we review the broad neutralizing antibodies (bnAbs) targeting the virus surface proteins, summarize their epitopes, broad spectrum and immunological mechanisms of action and discuss the design of universal influenza vaccines inspired by bnAbs.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ling, Zhiyang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Zhuo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sun, Bing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">No title available</subfield><subfield code="g">53</subfield><subfield code="w">(DE-627)ELV000891088</subfield><subfield code="x">1879-6257</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:53</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">53</subfield></datafield></record></collection>
|
| author |
Sun, Xiaoyu |
| spellingShingle |
Sun, Xiaoyu Broad neutralizing antibody-based strategies to tackle influenza |
| authorStr |
Sun, Xiaoyu |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000891088 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1879-6257 |
| topic_title |
Broad neutralizing antibody-based strategies to tackle influenza |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
No title available |
| hierarchy_parent_id |
ELV000891088 |
| hierarchy_top_title |
No title available |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000891088 |
| title |
Broad neutralizing antibody-based strategies to tackle influenza |
| ctrlnum |
(DE-627)ELV007849214 (ELSEVIER)S1879-6257(22)00014-1 |
| title_full |
Broad neutralizing antibody-based strategies to tackle influenza |
| author_sort |
Sun, Xiaoyu |
| journal |
No title available |
| journalStr |
No title available |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
zzz |
| author_browse |
Sun, Xiaoyu Ling, Zhiyang Yang, Zhuo Sun, Bing |
| container_volume |
53 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Sun, Xiaoyu |
| doi_str_mv |
10.1016/j.coviro.2022.101207 |
| author2-role |
verfasserin |
| title_sort |
broad neutralizing antibody-based strategies to tackle influenza |
| title_auth |
Broad neutralizing antibody-based strategies to tackle influenza |
| abstract |
Influenza viruses cause occasional pandemics and annual epidemics, thus persist as a threat to human society. The high variability of viral envelope proteins resulting from antigenic shift and antigenic drift allows influenza viruses to escape human herd immunity. During the past decade, along with the breakthroughs of human monoclonal antibody technologies, many broad reactive monoclonal antibodies (mAbs) that neutralize diverse influenza subtypes have been isolated and characterized. The achievements in this field have provided potential candidates of anti-influenza therapeutics and shed light on the design of universal influenza vaccines. Here, we review the broad neutralizing antibodies (bnAbs) targeting the virus surface proteins, summarize their epitopes, broad spectrum and immunological mechanisms of action and discuss the design of universal influenza vaccines inspired by bnAbs. |
| abstractGer |
Influenza viruses cause occasional pandemics and annual epidemics, thus persist as a threat to human society. The high variability of viral envelope proteins resulting from antigenic shift and antigenic drift allows influenza viruses to escape human herd immunity. During the past decade, along with the breakthroughs of human monoclonal antibody technologies, many broad reactive monoclonal antibodies (mAbs) that neutralize diverse influenza subtypes have been isolated and characterized. The achievements in this field have provided potential candidates of anti-influenza therapeutics and shed light on the design of universal influenza vaccines. Here, we review the broad neutralizing antibodies (bnAbs) targeting the virus surface proteins, summarize their epitopes, broad spectrum and immunological mechanisms of action and discuss the design of universal influenza vaccines inspired by bnAbs. |
| abstract_unstemmed |
Influenza viruses cause occasional pandemics and annual epidemics, thus persist as a threat to human society. The high variability of viral envelope proteins resulting from antigenic shift and antigenic drift allows influenza viruses to escape human herd immunity. During the past decade, along with the breakthroughs of human monoclonal antibody technologies, many broad reactive monoclonal antibodies (mAbs) that neutralize diverse influenza subtypes have been isolated and characterized. The achievements in this field have provided potential candidates of anti-influenza therapeutics and shed light on the design of universal influenza vaccines. Here, we review the broad neutralizing antibodies (bnAbs) targeting the virus surface proteins, summarize their epitopes, broad spectrum and immunological mechanisms of action and discuss the design of universal influenza vaccines inspired by bnAbs. |
| collection_details |
GBV_USEFLAG_U SYSFLAG_U GBV_ELV |
| title_short |
Broad neutralizing antibody-based strategies to tackle influenza |
| remote_bool |
true |
| author2 |
Ling, Zhiyang Yang, Zhuo Sun, Bing |
| author2Str |
Ling, Zhiyang Yang, Zhuo Sun, Bing |
| ppnlink |
ELV000891088 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1016/j.coviro.2022.101207 |
| up_date |
2024-07-06T17:40:38.253Z |
| _version_ |
1803852330569826304 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV007849214</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230509145018.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230507s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.coviro.2022.101207</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV007849214</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1879-6257(22)00014-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sun, Xiaoyu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Broad neutralizing antibody-based strategies to tackle influenza</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Influenza viruses cause occasional pandemics and annual epidemics, thus persist as a threat to human society. The high variability of viral envelope proteins resulting from antigenic shift and antigenic drift allows influenza viruses to escape human herd immunity. During the past decade, along with the breakthroughs of human monoclonal antibody technologies, many broad reactive monoclonal antibodies (mAbs) that neutralize diverse influenza subtypes have been isolated and characterized. The achievements in this field have provided potential candidates of anti-influenza therapeutics and shed light on the design of universal influenza vaccines. Here, we review the broad neutralizing antibodies (bnAbs) targeting the virus surface proteins, summarize their epitopes, broad spectrum and immunological mechanisms of action and discuss the design of universal influenza vaccines inspired by bnAbs.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ling, Zhiyang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Zhuo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sun, Bing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">No title available</subfield><subfield code="g">53</subfield><subfield code="w">(DE-627)ELV000891088</subfield><subfield code="x">1879-6257</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:53</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">53</subfield></datafield></record></collection>
|
| score |
7.3994036 |